Medical device company DexCom (NASDAQ:DXCM) will be reporting earnings tomorrow after the bell. Here’s what investors should ...

The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5% ...

Discover 9 top dividend stocks with 10%+ 5-year return potential based on my valuations and in-depth analysis. Click here.

ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...

Resmed has its origins in the 1980s, when Sydney sleep expert Dr Colin Sullivan converted a vacuum cleaner to deal with the ...

Analysts are bullish on these names. Let's find out why they rate them as buys. The post Where to invest $10,000 into ASX 200 ...

A look at the shareholders of ResMed Inc. (NYSE:RMD) can tell us which group is most powerful. With 69% stake, institutions possess the maximum shares in the company. In other words, the group stands ...

Not getting enough ZZZs or going to bed late into the night can have an adverse impact on your health and well being. Here’s ...

William Blair lowered their Q3 2025 EPS estimates for ResMed in a research report issued on Monday, February 3rd. William Blair analyst M. Andrew now anticipates that the medical equipment provider ...

Prestige Consumer Healthcare witnesses continued international growth in the third quarter, banking on strong sales of the Hydralyte brand.

Shares of ResMed Inc. RMD shed 2.23% to $237.18 Thursday, on what proved to be an all-around mixed trading session for the ...